ES2056075T3 - Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso. - Google Patents

Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso.

Info

Publication number
ES2056075T3
ES2056075T3 ES88106941T ES88106941T ES2056075T3 ES 2056075 T3 ES2056075 T3 ES 2056075T3 ES 88106941 T ES88106941 T ES 88106941T ES 88106941 T ES88106941 T ES 88106941T ES 2056075 T3 ES2056075 T3 ES 2056075T3
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
hiv
human immunodeficiency
procedures
specific antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88106941T
Other languages
English (en)
Inventor
Alan Ray Flesher
Mary Kathleen Shriver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/105,761 external-priority patent/US5104790A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Application granted granted Critical
Publication of ES2056075T3 publication Critical patent/ES2056075T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PROVEEN ANTICUERPOS MONOCLONICOS CAPACES DE ENCERRARSE INTERNAMENTE DENTRO DE LAS PROTEINAS NUCLEICAS DEL VIRUS DE INMUNODEFICIENCIA E INMORTALIZANDO LINEAS DE CELULAS PRODUCIENDO ESTOS ANTICUERPOS.LOS ANTICUERPOS MONOCLONICOS SE USAN DE INFINIDAD DE FORMAS, INCLUYENDO DETECCION DE VI ANTIGENOS EN MUESTRAS BIOLOGICAS. USANDO ESTOS METODOS PUEDE SER IDENTIFICADO QUIEN ESTA INFECTADO CON VI ,PERO NO HA DESARROLLADO ANTICUERPOS. LOS METODOS TIENEN EMPLEO EN ANALISIS IN VITRO DE CRECIMIENTO DEL VI, Y ES EFICAZ CON AGENTES TERAPEUTICOS Y VACUNAS.
ES88106941T 1987-05-01 1988-04-29 Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso. Expired - Lifetime ES2056075T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29
US07/105,761 US5104790A (en) 1987-06-29 1987-10-07 Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use

Publications (1)

Publication Number Publication Date
ES2056075T3 true ES2056075T3 (es) 1994-10-01

Family

ID=27366599

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88106941T Expired - Lifetime ES2056075T3 (es) 1987-05-01 1988-04-29 Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso.

Country Status (9)

Country Link
EP (1) EP0290893B1 (es)
JP (1) JP3142126B2 (es)
KR (1) KR880014376A (es)
AT (1) ATE105938T1 (es)
CA (1) CA1339363C (es)
DE (1) DE3889581T2 (es)
ES (1) ES2056075T3 (es)
IE (1) IE65408B1 (es)
NZ (1) NZ224385A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
SE9101863D0 (sv) * 1991-06-13 1991-06-13 Replico Medical Ab Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
FR2731225B1 (fr) * 1995-03-03 2003-10-31 Pasteur Institut Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
ES2293643T5 (es) 1994-10-20 2012-02-02 Institut Pasteur Secuencias nucleotídicas de antígenos retrovíricos vih-1 del grupo (o subgrupo) o.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US898273A (en) * 1908-01-18 1908-09-08 Charles Silger Cigar-banding device.
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease

Also Published As

Publication number Publication date
DE3889581T2 (de) 1994-10-20
IE881282L (en) 1988-11-01
ATE105938T1 (de) 1994-06-15
EP0290893A1 (en) 1988-11-17
CA1339363C (en) 1997-08-26
NZ224385A (en) 1991-08-27
DE3889581D1 (de) 1994-06-23
IE65408B1 (en) 1995-10-18
JPS6463392A (en) 1989-03-09
KR880014376A (ko) 1988-12-23
JP3142126B2 (ja) 2001-03-07
EP0290893B1 (en) 1994-05-18

Similar Documents

Publication Publication Date Title
SE8604007L (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
ES2056075T3 (es) Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso.
ES2050114T3 (es) Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia.
DE69033728D1 (de) Impfstoffkonjugat
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
DK56389D0 (da) Forhindring og behandling af retroviralt frembragte sygdomme
IT1141277B (it) Polipeptide sintetico attivo come antigene,e procedimento per la sua preparazione
DE3272729D1 (en) Hepatitis-a viruses adapted to human fibroblast cells
ATE106945T1 (de) Methoden und materialien für die hiv-erkennung und therapie.
ES2095258T3 (es) Nuevo virus de la enfermedad de la bolsa infecciosa.
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
DE3670307D1 (de) Spezifische mycoplasma-membran-antigene und -antikoerper sowie deren klinische verwendungen.
GR890100219A (el) Ανθρωπινα μονοκλωνικα αντισωματα που ειδικα αναγνωριζουν κυτταραιου λυσσας κυτταρα που παραγουν τα ιδια, διαμορφωσεις που περιε χουν τα ιδια και παραγωγη ολων αυτων.
ATE39054T1 (de) Dns viren-vakzin.
GB1105178A (en) Improvements in or relating to antigens suitable for the diagnosis of hepatitis
Erdei et al. Use of the ELISA-test for the serological screening for Aujeszky's virus infection in large-scale swine stocks.
Chauhan et al. Additional studies on hydrazines of Agaricus bisporus (AB): Analysis, metabolism and carcinogenesis
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
Khairy The Prevalelnce of the Epstein-Barr virus In some Egyptian population
Chorváth et al. Cell surface glycoproteins of human leukaemia cells: Electrophoretic analysis and characterization by some monoclonal antibodies
Chermann et al. Evidence for the possible role of a new family of retroviruses in aids
WO1991008771A3 (fr) Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 290893

Country of ref document: ES